{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:56:04Z","timestamp":1790607364932,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,7,29]],"date-time":"2012-07-29T00:00:00Z","timestamp":1343520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s12031-012-9861-y","type":"journal-article","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T16:45:09Z","timestamp":1343493909000},"page":"473-481","source":"Crossref","is-referenced-by-count":42,"title":["Serotonin 5-HT7 Receptor Blockade Reverses Behavioral Abnormalities in PACAP-Deficient Mice and Receptor Activation Promotes Neurite Extension in Primary Embryonic Hippocampal Neurons"],"prefix":"10.1007","volume":"48","author":[{"given":"Minako","family":"Tajiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Hayata-Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Seiriki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Hazama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Shintani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemichi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,29]]},"reference":[{"key":"9861_CR1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1521-8","volume":"205","author":"AI Abbas","year":"2009","unstructured":"Abbas AI, Hedlund PB, Huang XP, Tran TB, Meltzer HY, Roth BL (2009) Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology (Berl) 205:119\u2013128","journal-title":"Psychopharmacology (Berl)"},{"key":"9861_CR2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0091-3057(98)00141-5","volume":"62","author":"TM Ballard","year":"1999","unstructured":"Ballard TM, McAllister KH (1999) Acutely administered clozapine does not modify naloxone-induced withdrawal jumping in morphine-dependent mice. Pharmacol Biochem Behav 62:285\u2013290","journal-title":"Pharmacol Biochem Behav"},{"key":"9861_CR3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neubiorev.2004.09.002","volume":"28","author":"PA Dudchenko","year":"2004","unstructured":"Dudchenko PA (2004) An overview of the tasks used to test working memory in rodents. Neurosci Biobehav Rev 28:699\u2013709","journal-title":"Neurosci Biobehav Rev"},{"key":"9861_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0920-9964(01)00323-1","volume":"7","author":"SZ East","year":"2002","unstructured":"East SZ, Burnet PW, Kerwin RW, Harrison PJ (2002) An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia. Schizophr Res 7:15\u201326","journal-title":"Schizophr Res"},{"key":"9861_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbr.2007.08.012","volume":"186","author":"T Enomoto","year":"2008","unstructured":"Enomoto T, Ishibashi T, Tokuda K, Ishiyama T, Toma S, Ito A (2008) Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats. Behav Brain Res 186:197\u2013207","journal-title":"Behav Brain Res"},{"key":"9861_CR6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/FBP.0b013e3282f62d8c","volume":"19","author":"RG Galici","year":"2008","unstructured":"Galici RG, Boggs JD, Miller KL, Bonaventure P, Atack JR (2008) Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity. Behav Pharmacol 19:153\u2013159","journal-title":"Behav Pharmacol"},{"key":"9861_CR7","first-page":"164","volume":"195","author":"A Gasbarri","year":"2008","unstructured":"Gasbarri A, Cifariello A, Pompili A, Meneses A (2008) Effect of 5-HT7 antagonist SB-269970 in the modulation of working and reference memory in the rat. BehavBrain Res 195:164\u2013170","journal-title":"BehavBrain Res"},{"key":"9861_CR8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1471-4159.2009.06168.x","volume":"110","author":"H Hashimoto","year":"2009","unstructured":"Hashimoto H, Hashimoto R, Shintani N et al (2009) Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone. J Neurochem 110:595\u2013602","journal-title":"J Neurochem"},{"key":"9861_CR9","doi-asserted-by":"crossref","first-page":"13355","DOI":"10.1073\/pnas.231094498","volume":"98","author":"H Hashimoto","year":"2001","unstructured":"Hashimoto H, Shintani N, Tanaka K et al (2001) Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase activating polypeptide (PACAP). Proc Natl Acad Sci USA 98:13355\u201313360","journal-title":"Proc Natl Acad Sci USA"},{"key":"9861_CR10","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/sj.mp.4001982","volume":"12","author":"R Hashimoto","year":"2007","unstructured":"Hashimoto R, Hashimoto H, Shintani N et al (2007) Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol Psychiatry 12:1026\u20131032","journal-title":"Mol Psychiatry"},{"key":"9861_CR11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.neulet.2009.11.019","volume":"468","author":"R Hashimoto","year":"2010","unstructured":"Hashimoto R, Hashimoto H, Shintani N et al (2010) Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder. Neurosci Lett 468:300\u2013302","journal-title":"Neurosci Lett"},{"key":"9861_CR12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-009-1626-0","volume":"206","author":"PB Hedlund","year":"2009","unstructured":"Hedlund PB (2009) The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology 206:345\u2013354","journal-title":"Psychopharmacology"},{"key":"9861_CR13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-2999(00)00162-X","volume":"395","author":"M Hiramatsu","year":"2000","unstructured":"Hiramatsu M, Inoue K (2000) Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and\/or memory. Eur J Pharmacol 395:149\u2013156","journal-title":"Eur J Pharmacol"},{"key":"9861_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-011-2251-2","volume":"217","author":"M Horiguchi","year":"2011","unstructured":"Horiguchi M, Huang M, Meltzer HY (2011) The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats. Psychopharmacology (Berl) 217:13\u201324","journal-title":"Psychopharmacology (Berl)"},{"key":"9861_CR15","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/sj.npp.1300901","volume":"31","author":"M Ikeda","year":"2006","unstructured":"Ikeda M, Iwata N, Kitajima T et al (2006) Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population. Neuropsychopharmacology 31:866\u2013871","journal-title":"Neuropsychopharmacology"},{"key":"9861_CR16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2007.06.058","volume":"572","author":"T Ishiyama","year":"2007","unstructured":"Ishiyama T, Tokuda K, Ishibashi T, Ito A, Toma S, Ohno Y (2007) Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test. Eur J Pharmacol 572:160\u2013170","journal-title":"Eur J Pharmacol"},{"key":"9861_CR17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0006-3223(01)01267-7","volume":"50","author":"C Konradi","year":"2001","unstructured":"Konradi C, Heckers S (2001) Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biol Psychiatry 50:729\u2013742","journal-title":"Biol Psychiatry"},{"key":"9861_CR18","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1523\/JNEUROSCI.1790-05.2005","volume":"25","author":"E Kvachnina","year":"2005","unstructured":"Kvachnina E, Liu G, Dityatev A et al (2005) 5-HT7 receptor is coupled to G\u03b1 subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. J Neuroscience 25:7821\u20137830","journal-title":"J Neuroscience"},{"key":"9861_CR19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1601-183X.2009.00486.x","volume":"8","author":"D Leo","year":"2009","unstructured":"Leo D, Adriani W, Cavaliere C et al (2009) Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology. Genes Brain Behav 8:356\u2013368","journal-title":"Genes Brain Behav"},{"key":"9861_CR20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pnpbp.2009.01.006","volume":"33","author":"YC Li","year":"2009","unstructured":"Li YC, Wang FM, Pan Y et al (2009) Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog Neuropsychopharmacol Biol Psychiatry 33:435\u2013449","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9861_CR21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1385\/JMN:27:1:043","volume":"27","author":"XH Lu","year":"2005","unstructured":"Lu XH, Dwyer DS (2005) Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K\/AKT, ERK, and pertussis toxin-sensitive pathways. J Mol Neurosci 27:43\u201364","journal-title":"J Mol Neurosci"},{"key":"9861_CR22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(95)00254-I","volume":"280","author":"T Matsuda","year":"1995","unstructured":"Matsuda T, Somboonthum P, Suzuki M, Asano S, Baba A (1995) Antidepressant-like effect by postsynaptic 5-HT1A receptor activation in mice. Eur J Pharmacol 280:235\u2013238","journal-title":"Eur J Pharmacol"},{"key":"9861_CR23","first-page":"64","volume":"3","author":"HY Meltzer","year":"1995","unstructured":"Meltzer HY (1995) Role of serotonin in the action of atypical antipsychotic drugs. Clin Neurosci 3:64\u201375","journal-title":"Clin Neurosci"},{"key":"9861_CR24","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1176\/appi.ajp.2011.10060907","volume":"168","author":"HY Meltzer","year":"2011","unstructured":"Meltzer HY, Cucchiaro J, Silva R et al (2011) Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study. Am J Psychiatry 168:957\u2013967","journal-title":"Am J Psychiatry"},{"key":"9861_CR25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbr.2004.04.026","volume":"155","author":"A Meneses","year":"2004","unstructured":"Meneses A (2004) Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian\/instrumental learning task. Behav Brain Res 155:275\u2013282","journal-title":"Behav Brain Res"},{"key":"9861_CR26","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1440-1681.2007.04608.x","volume":"34","author":"LS Nandam","year":"2007","unstructured":"Nandam LS, Jhaveri D, Bartlett P (2007) 5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression. Clin Exp Pharmacol Physiol 34:546\u2013551","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"9861_CR27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0891-0618(00)00092-2","volume":"21","author":"JF Neumaier","year":"2001","unstructured":"Neumaier JF, Sexton TJ, Yracheta J, Diaz AM, Brownfield M (2001) Localization of 5-HT7 receptors in rat brain by mmunocytochemistry, in situ hybridization, and agonist stimulated cFos expression. J Chem Neuroanat 21:63\u201373","journal-title":"J Chem Neuroanat"},{"key":"9861_CR28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","volume":"177","author":"B Petit-Demouliere","year":"2005","unstructured":"Petit-Demouliere B, Chenu F, Bourin M (2005) Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 177:245\u2013255","journal-title":"Psychopharmacology (Berl)"},{"key":"9861_CR29","first-page":"73","volume":"280","author":"G Perrault","year":"1997","unstructured":"Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B (1997) Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2\/D3 dopamine receptor antagonist activity and limbic selectivity. J Pharmacol Exp Ther 280:73\u201382","journal-title":"J Pharmacol Exp Ther"},{"key":"9861_CR30","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730\u2013732","journal-title":"Nature"},{"key":"9861_CR31","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0091-3057(01)00744-4","volume":"71","author":"B Pouzet","year":"2002","unstructured":"Pouzet B, Didriksen M, Arnt J (2002) Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia. Pharmacol Biochem Behav 71:655\u2013665","journal-title":"Pharmacol Biochem Behav"},{"key":"9861_CR32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00002826-199510000-00008","volume":"18","author":"RB Rosse","year":"1995","unstructured":"Rosse RB, Mastropaolo J, Sussman DM, Koetzner L, Morn CB, Deutsch SI (1995) Computerized measurement of MK-801-elicited popping and hyperactivity in mice. Clin Neuropharmacol 18:448\u2013457","journal-title":"Clin Neuropharmacol"},{"key":"9861_CR33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10401239409148985","volume":"6","author":"BL Roth","year":"1994","unstructured":"Roth BL (1994) Multiple serotonin receptors: clinical and experimental aspects. Ann Clin Psychiatry 6:67\u201378","journal-title":"Ann Clin Psychiatry"},{"key":"9861_CR34","first-page":"17","volume":"174","author":"BL Roth","year":"2004","unstructured":"Roth BL, Hanizavareh SM, Blum AE (2004) Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. Psychopharmacology (Berl) 174:17\u201324","journal-title":"Psychopharmacology (Berl)"},{"key":"9861_CR35","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1073\/pnas.90.18.8547","volume":"90","author":"M Ruat","year":"1993","unstructured":"Ruat M, Traiffort E, Leurs R, Tardivel-Lacombe J, Diaz J, Arrang JM (1993) Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci USA 90:8547\u20138551","journal-title":"Proc Natl Acad Sci USA"},{"key":"9861_CR36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00212843","volume":"94","author":"M Sarter","year":"1988","unstructured":"Sarter M, Bodewitz G, Stephens DN (1988) Attenuation of scopolamineinduced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology 94:491\u2013495","journal-title":"Psychopharmacology"},{"key":"9861_CR37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biopsych.2006.12.011","volume":"63","author":"S Semenova","year":"2008","unstructured":"Semenova S, Geyer MA, Sutcliffe JG, Markou A, Hedlund PB (2008) Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition. Biol Psychiatry 63:98\u2013105","journal-title":"Biol Psychiatry"},{"key":"9861_CR38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1196\/annals.1317.079","volume":"1070","author":"N Shintani","year":"2006","unstructured":"Shintani N, Hashimoto H, Tanaka K et al (2006) Serotonergic inhibition of intense jumping behavior in mice lacking PACAP (Adcyap1\u2212\/\u2212). Ann NY Acad Sci 1070:545\u2013549","journal-title":"Ann NY Acad Sci"},{"key":"9861_CR39","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1523\/JNEUROSCI.4376-05.2006","volume":"26","author":"K Tanaka","year":"2006","unstructured":"Tanaka K, Shintani N, Hashimoto H et al (2006) Psychostimulant induced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice. J Neurosci 26:5091\u20135097","journal-title":"J Neurosci"},{"key":"9861_CR40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/pr.109.001370","volume":"61","author":"D Vaudry","year":"2009","unstructured":"Vaudry D, Falluel-Morel A, Bourgault S et al (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283\u2013357","journal-title":"Pharmacol Rev"},{"key":"9861_CR41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2006.09.064","volume":"553","author":"A Wesolowska","year":"2006","unstructured":"Wesolowska A, Nikiforuk A, Stachowicz K (2006a) Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. Eur J Pharmacol 553:185\u2013190","journal-title":"Eur J Pharmacol"},{"key":"9861_CR42","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neuropharm.2006.04.017","volume":"51","author":"A Wesolowska","year":"2006","unstructured":"Wesolowska A, Nikiforuk A, Stachowicz K, Tatarczynska E (2006b) Effect of the selective 5-HT(7) receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 51:578\u2013586","journal-title":"Neuropharmacology"},{"key":"9861_CR43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2006.10.001","volume":"555","author":"A Wesolowska","year":"2007","unstructured":"Wesolowska A, Tatarczynska E, Nikiforuk A, Chojnacka-Wojcik E (2007) Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice. Eur J Pharmacol 555:43\u201347","journal-title":"Eur J Pharmacol"},{"key":"9861_CR44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuroscience.2011.02.042","volume":"182","author":"Y Xu","year":"2011","unstructured":"Xu Y, Zhang C, Wang R, Govindarajan SS et al (2011) Corticosterone induced morphological changes of hippocampal and amygdaloid cell lines are dependent on 5-HT7 receptor related signal pathway. Neuroscience 182:71\u201381","journal-title":"Neuroscience"},{"key":"9861_CR45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1124\/mol.111.076141","volume":"81","author":"EY Yuen","year":"2012","unstructured":"Yuen EY, Li X, Wei J, Horiguchi M, Meltzer HY, Yan Z (2012) The novel antipsychotic drug lurasidone enhances N-methyl-d-aspartate receptor-mediated synaptic responses. Mol Pharmacol 81:113\u2013119","journal-title":"Mol Pharmacol"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-012-9861-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-012-9861-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-012-9861-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:24:51Z","timestamp":1559442291000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-012-9861-y"}},"subtitle":["Therapeutic Implications for Psychiatric Disorders"],"short-title":[],"issued":{"date-parts":[[2012,7,29]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["9861"],"URL":"https:\/\/doi.org\/10.1007\/s12031-012-9861-y","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,29]]}}}